• 1
    Yashiro A. A kind of plasmacytosis: primary cutaneous plasmacytoma? Jpn J Dermatol 1976; 86: 910.
  • 2
    Kitamura K, Tamura N, Hatano H et al. A case of plasmacytosis with multiple peculiar eruptions. J Dermatol 1980; 7: 3419.
  • 3
    Watanabe S, Ohara K, Kukita A, Mori S. Systemic plasmacytosis: a syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch Dermatol 1986; 122: 131420.
  • 4
    Amin HM, McLaughlin P, Rutherford CJ et al. Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States. Am J Dermatopathol 2002; 24: 2415.
  • 5
    Leonard AL, Meehan SA, Ramsey D et al. Cutaneous and systemic plasmacytosis. J Am Acad Dermatol 2007; 56: 3840.
  • 6
    Ma HJ, Liu W, Li Y et al. Cutaneous and systemic plasmacytosis: a Chinese case. J Dermatol 2008; 35: 53640.
  • 7
    Shadel BN, Frater JL, Gapp JD, Hurley MY. Cutaneous and systemic plasmacytosis in an Asian male born in the North American continent: a controversial entity potentially related to multicentric Castleman disease. J Cutan Pathol 2010; 37: 697702.
  • 8
    Tada Y, Komine M, Suzuki S et al. Plasmacytosis: systemic or cutaneous, are they distinct? Acta Derm Venereol 2000; 80: 2335.
  • 9
    Uhara H, Saida T, Ikegawa S et al. Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology 1994; 189: 2515.
  • 10
    Ahn JJ, Yang YS, Shin MK et al. Case of isolated benign primary cutaneous plasmacytosis in a child. J Dermatol 2011; 38: 3647.
  • 11
    Lee JS, Chiam L, Tan KB et al. Extensive hyperpigmented plaques in a Chinese Singaporean woman: a case of cutaneous plasmacyotosis. Am J Dermatopathol 2011; 33: 498503.
  • 12
    Gonz·lez-LÛpez MA, Gonz·lez-Vela MC, Blanco R et al. Cutaneous plasmacytosis limited to the extremities in a white patient: an unusual clinical picture. Cutis 2010; 86: 1437.
  • 13
    Cannistraci C, Lesnoni La Parola I, Donati P et al. Case of benign cutaneous plamacytosis: immunohistochemical and flow cytometry study. J Eur Acad Dermatol Venereol 2010; 24: 1112.
  • 14
    Miyagawa-Hayashino A, Matsumura Y, Kawakami F et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis – is this a cutaneous manifestation of IgG4-related disease? Hum Pathol 2009; 40: 126977.
  • 15
    Gilliam AC, Mullen RH, Oviedo G et al. Isolated benign primary cutaneous plasmacytosis in children: two illustrative cases. Arch Dermatol 2009; 145: 299302.
  • 16
    Honda R, Cerroni L, Tanikawa A et al. Cutaneous plasmacytosis: Report of 6 cases with or without systemic involvement. J Am Acad Dermatol 2013; 68(6): 97885.
  • 17
    Chen H, Xue Y, Jiang Y et al. Cutaneous and systemic plasmacytosis showing histopathologic features as mixed-type Castleman disease: a case report. Am J Dermatopathol 2012; 34: 5536.
  • 18
    Shimizu S, Tanaka M, Shimizu H, Han-yaku H. Is cutaneous plasmacytosis a distinct clinical entity? J Am Acad Dermatol 1997; 36: 87680.
  • 19
    LÛpez-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL et al. Cutaneous plasmacytosis: report of a case in a white man. J Am Acad Dermatol 1994; 31: 897900.
  • 20
    Jayaraman AG, Cesca C, Kohler S. Cutaneous plasmacytosis: A report of five cases with immunohistochemical evaluation for HHV-8 expression. Am J Dermatopathol 2006; 28: 938.
  • 21
    Cheng R, Hong YU, Ming LI, Yao Z. Cutaneous and systemic plasmacytosis. Chin Med J 2012; 125: 41567.
  • 22
    Carey WP, Rico MJ, Nierodzik M, Sidhu G. Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. J Am Acad Dermatol 1998; 38: 62931.
  • 23
    Imai Y, Takahashi M, Takahara T et al. A case of lymphoid interstitial pneumonia with accompanying intensive polyclonal gammopathy and skin eruption. J Transportation Med 1977; 31: 1107.
  • 24
    Ide M, Fujino O, Inomoto T et al. A case of idiopathic lymphadenopathy with polyclonal hyperimmunoglobulinemia with plasmacystic infiltration to lung, kidney and lymph nodes. Naika (Tokyo) 1993; 72: 5936.
  • 25
    Kodama A, Tani M, Hori K et al. Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinemia: significant serum interleukin-6 levels. Br J Dermatol 1992; 127: 4953.
  • 26
    Tzung TY, Wu KH Wu JC, Tseng HH. Primary cutaneous plasmacytosis successfully treated with topical photodynamic therapy. Acta Derm Venereol 2005; 85: 5423.
  • 27
    Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009; 16: 23646.
  • 28
    Haque M, Hou JS, Hisamichi K et al. Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis. Clin Lymphoma Myeloma Leuk 2011; 11: 45361.
  • 29
    Higashi Y, Kanekura T, Sakomoto R et al. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis. Dermatology 2007; 214: 1703.
  • 30
    Kayasut K, Le Tourneau A, Rio B et al. Are multicentric Castlemanís disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity? Histopathology 2006; 49: 5578.
  • 31
    Yamamoto T, Katayama I, Nishioka K. Increased plasma interleukin-6 in cutaneous plamacytoma: the effect of intralesional steroid therapy. Br J Dermatol 1997; 137: 6316.
  • 32
    Okada H, Kano R, Waranabe S. Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with systemic plasmacytosis. Br J Dermatol 1999; 141: 9423.
  • 33
    Martin JM, Calduch L, Monteagudo C et al. Cutaneous plasmacytosis associated with lung and anal carcinomas. J Eur Acad Dermatol Venereol 2006; 20: 42831.
  • 34
    Rock B, Martins CR, Theofilopoulos AN et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus. N Engl J Med 1989; 320: 14639.
  • 35
    Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 53951.
  • 36
    Miura H, Itami S, Yoshikawa K. Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment. J Am Acad Dermatol 2003; 49: 11956.
  • 37
    Hafner C, Hohenleutner U, Babilas P et al. Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with tropical pimecrolimus. Dermatology 2006; 213: 1635.
  • 38
    Kaneda M, Kuroda K, Fujita M, Shinkai H. Successful treatment with topical PUVA of nodular cutaneous plasmacytosis associated with alopecia of the scalp. Clin Exp Dermatol 1996; 21: 3604.
  • 39
    Lee DW, Choi SW, Park JW, Cho BK. Systemic plasmacytosis: a case which improved with melphalan. J Dermatol 1995; 22: 2059.